Loading insider details...
Beta
Latest Form 4 (Jun 22, 2026): Grant/Award of 51,700 EDIT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 22, 2026 | Editas Medicine, Inc. (EDIT) | Grant/Award | 51,700 | n/a |
| Feb 18, 2026 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 700,000 | n/a |
| Jun 10, 2025 | Editas Medicine, Inc. (EDIT) | Grant/Award | 37,500 | n/a |
| Feb 18, 2025 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 223,500 | n/a |
| Nov 12, 2024 | C4 Therapeutics, Inc. (CCCC) | Exercise/Conversion | 12,500 | n/a |
| Sep 17, 2024 | C4 Therapeutics, Inc. (CCCC) | Exercise/Conversion | 7,500 | n/a |
| Jun 3, 2024 | Editas Medicine, Inc. (EDIT) | Grant/Award | 25,000 | n/a |
| Feb 15, 2024 | C4 Therapeutics, Inc. (CCCC) | Tax Withholding | 6,560 | $51.8K |
| Feb 15, 2024 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 103,400 | n/a |
| Sep 19, 2023 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 489,600 | n/a |